UK markets open in 3 hours 10 minutes

Escalon Medical Corp. (ESMC)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.24000.0000 (0.00%)
At close: 09:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.78M
Enterprise value 2.74M
Trailing P/E 4.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.26
Price/book (mrq)1.49
Enterprise value/revenue 0.22
Enterprise value/EBITDA 3.64

Trading information

Stock price history

Beta (5Y monthly) -0.52
52-week change 3242.86%
S&P500 52-week change 322.64%
52-week high 30.3900
52-week low 30.0700
50-day moving average 30.2166
200-day moving average 30.2447

Share statistics

Avg vol (3-month) 34.05k
Avg vol (10-day) 3350
Shares outstanding 57.42M
Implied shares outstanding 67.42M
Float 87.27M
% held by insiders 11.90%
% held by institutions 10.00%
Shares short (31 Oct 2016) 42.01k
Short ratio (31 Oct 2016) 40.31
Short % of float (31 Oct 2016) 40.03%
Short % of shares outstanding (31 Oct 2016) 40.03%
Shares short (prior month 30 Sept 2016) 42.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 324 Nov 1997

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 5.54%
Operating margin (ttm)-2.46%

Management effectiveness

Return on assets (ttm)9.47%
Return on equity (ttm)45.91%

Income statement

Revenue (ttm)12.38M
Revenue per share (ttm)1.67
Quarterly revenue growth (yoy)-4.50%
Gross profit (ttm)N/A
EBITDA 753.78k
Net income avi to common (ttm)450.78k
Diluted EPS (ttm)0.0600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)390.44k
Total cash per share (mrq)0.05
Total debt (mrq)707.67k
Total debt/equity (mrq)38.52%
Current ratio (mrq)1.64
Book value per share (mrq)0.16

Cash flow statement

Operating cash flow (ttm)157.65k
Levered free cash flow (ttm)-127.25k